Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease. - Wikidata - awgldk - TriplyDB

Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease.

Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease.

http://www.wikidata.org/entity/Q38071935

about

Glycosyltransferases and non-alcoholic fatty liver disease Oily fish, coffee and walnuts: Dietary treatment for nonalcoholic fatty liver disease The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis.Exercise restores muscle stem cell mobilization, regenerative capacity and muscle metabolic alterations via adiponectin/AdipoR1 activation in SAMP10 mice Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines.The Correlation Between Serum Adipokines and Liver Cell Damage in Non-Alcoholic Fatty Liver Disease Role of innate immune response in non-alcoholic Fatty liver disease: metabolic complications and therapeutic tools.Characteristics of resistin in rheumatoid arthritis angiogenesis.Adiponectin Induces Oncostatin M Expression in Osteoblasts through the PI3K/Akt Signaling Pathway.Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD.The association of circulating levels of complement-C1q TNF-related protein 5 (CTRP5) with nonalcoholic fatty liver disease and type 2 diabetes: a case-control study Reduced adiponectin signaling due to weight gain results in nonalcoholic steatohepatitis through impaired mitochondrial biogenesis.The role of ADIPOQ methylation in curcumin-administrated experimental nonalcoholic fatty liver disease.

P2860

Q26764913-643A4563-307D-4EAE-94BE-41A44D43B927 Q26784396-E90C5069-D244-48F4-9303-686765E50BA0 Q30382395-9BD9FB9D-2D44-447F-B6E2-3A5390191007 Q33813584-5674B67F-4FAE-4E54-9085-53303744777B Q36566846-C00C61FD-31A6-49B8-9635-AB9306BB9FAC Q37001197-EABCCBAD-E186-40FD-9EC6-545CF23B1A97 Q38209324-73D25FF6-4AAB-444C-B35A-2685E78D2DD3 Q38729894-D9530DA3-3A49-4310-9FDA-02F53A14CBF1 Q38808327-8BF94C09-BFBD-46E5-A4E8-836795503345 Q39112497-9BF5E312-9F76-49AB-AD72-0B1C5F7C0A27 Q42733670-58F28026-260B-4B52-9447-D6DBBC735292 Q44993268-AA5A6870-4278-4EEB-9317-2E95D8D906EB Q51061308-A23B9AF5-AC9F-436F-96C1-FE2832675FEA

P2860

Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease.

http://www.wikidata.org/entity/Q38071935

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease.

@en

type

label

Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease.

@en

prefLabel

Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease.

@en

P1433

Q38071935-DF3A4D98-3C4C-40DC-B474-15FAE9FD4AF1

P1476

Q38071935-63767E69-E1AD-40CB-A8DF-2A5302965742

P2093

Q38071935-1D9F48D0-A477-4708-A8FD-2FE758D9091E

Q38071935-61AFC1C2-B1BC-4515-A4A8-261130B83301

Q38071935-6D593588-2CCD-4C27-914D-01F5D40AA598

Q38071935-D5329BB5-6D48-44FD-83F6-ECFD4B67BCB6

P2860

Q38071935-00613CB9-028E-48C7-9481-FC33F04B3280

Q38071935-00C4B8D7-7751-4961-9268-779DA962BC6A

Q38071935-00D646C6-CE89-4668-A0EA-BE6382A0CA9E

Q38071935-011ECCE2-FD6F-422F-9B98-7F71F32B6745

Q38071935-036D26F0-6EFF-4FE8-823C-BD803ED8FC17

Q38071935-04FF1FBF-B110-4D3D-901B-976B51072DD4

Q38071935-078E7103-EBC3-452A-85D7-499A5A67D53C

Q38071935-0AA1939E-B11A-473C-9AE8-0B01C3A79F20

Q38071935-0C43857B-61A4-49D6-B48E-F28AE9BC2A6E

Q38071935-0CAC42F3-15ED-499F-ADF2-873B980F62C4

P2888

Q38071935-8D69995B-34A6-4719-A778-9B4067F3B931

P304

Q38071935-E4790CC0-354E-49C1-8FE5-D4E36E1FBD82

P31

Q38071935-2A9A1C05-2504-4916-AD9E-EC99B54E1E16

P356

Q38071935-44DFDBFA-0666-410F-82AC-A01CCFD5248E

P433

Q38071935-84C10B83-2A72-468C-B6F9-805D090B63EF

P478

Q38071935-31811B09-2F83-426A-B8C6-7B391049920B

P577

Q38071935-5829FB72-3236-4207-9D9B-33127F8F0183

P5875

Q38071935-FF5DABDE-B88C-4500-B816-CA9A2CB227BE

P6179

Q38071935-B94E0AD1-E4EF-4944-859D-DE33D51202FC

P698

Q38071935-C903D66D-CEC6-4C07-933E-C757840B68AE

P356

S10238-012-0227-0

P1433

Clinical and Experimental Medicine

P1476

Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease.

@en

P2093

George N Dalekos

http://www.w3.org/2001/XMLSchema#string

George Ntaios

http://www.w3.org/2001/XMLSchema#string

Konstantinos Makaritsis

http://www.w3.org/2001/XMLSchema#string

Nikolaos K Gatselis

http://www.w3.org/2001/XMLSchema#string

P2860

Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages

Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30)

Adiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosis

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

P2888

s10238-012-0227-0

P304

121-131

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10238-012-0227-0

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234069997

http://www.w3.org/2001/XMLSchema#string

P6179

1034851897

http://www.w3.org/2001/XMLSchema#string

P698

23292294

http://www.w3.org/2001/XMLSchema#string